11:11 AM EDT, 05/31/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts rose Friday morning, gaining 0.61% to 1,418.20 on the S&P Europe Select ADR Index. The index is poised to end the week lower.

From continental Europe, the gainers were led by biotech firm BioNTech (BNTX) and pharmaceutical company Ascendis Pharma ( ASND ) , which rose 4% and 3.5% respectively. They were followed by biopharmaceutical company Cellectis ( CLLS ) and oil and gas company TotalEnergies (TTE), which increased 3.3% and 2.2% respectively.

The decliners from continental Europe were led by biopharmaceutical companies Genfit ( GNFT ) and DBV Technologies ( DBVT ) , which fell 14% and 5.3% respectively. They were followed by semiconductor company Sequans Communications ( SQNS ) and hotel booking site trivago (TRVG), which dropped 3.4% and 2.3% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Adaptimmune Therapeutics ( ADAP ) and Verona Pharma ( VRNA ) , which climbed 10% and 6.5% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and biotech firm Trinity Biotech ( TRIB ) , which were up 4.1% and 3.6% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company NuCana ( NCNA ) and construction materials supplier CRH (CRH), which lost 2.4% and 2.1% respectively. They were followed by gas and electricity provider National Grid ( NGG ) and biopharmaceutical company Akari Therapeutics ( AKTX ) , which were down 1.3% and 0.9% respectively.